Milan, Italy

Carlotta Ronchi


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Carlotta Ronchi: Innovator in Heart Failure Treatment

Introduction

Carlotta Ronchi is a distinguished inventor based in Milan, Italy. She has made significant contributions to the field of medicine, particularly in the development of compounds for the treatment of heart failure. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving healthcare.

Latest Patents

Ronchi holds a patent for "17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure." This patent discloses compounds of formula (I), which include annular atoms in a five-membered carbocyclic or heterocyclic ring. These compounds are designed for use as medicaments, specifically targeting acute or chronic heart failure. The patent emphasizes the potential for oral administration of these compounds, highlighting their therapeutic applications.

Career Highlights

Throughout her career, Carlotta Ronchi has demonstrated a commitment to advancing medical science. Her work at Cvie Therapeutics Limited has positioned her as a key player in the development of innovative treatments. With her patent, she has contributed to the growing body of research aimed at addressing heart failure, a condition that affects millions worldwide.

Collaborations

Ronchi has collaborated with notable colleagues, including Alberto Cerri and Giuseppe Bianchi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the medical field.

Conclusion

Carlotta Ronchi's contributions to the treatment of heart failure through her innovative compounds exemplify her dedication to improving patient outcomes. Her patent and collaborative efforts reflect her significant role in the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…